Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Narcolepsy Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Narcolepsy Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Narcolepsy Therapeutics Overall Market Size
2.1 Global Narcolepsy Therapeutics Market Size: 2021 VS 2028
2.2 Global Narcolepsy Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Narcolepsy Therapeutics Players in Global Market
3.2 Top Global Narcolepsy Therapeutics Companies Ranked by Revenue
3.3 Global Narcolepsy Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Narcolepsy Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Narcolepsy Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Narcolepsy Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Narcolepsy Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Narcolepsy Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Narcolepsy Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Central nervous system stimulants
4.1.3 Sodium Oxybate
4.1.4 Selective Serotonin Reuptake Inhibitor (SSRI)
4.1.5 Tricyclic Antidepressants
4.1.6 Others
4.2 By Type - Global Narcolepsy Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Narcolepsy Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Narcolepsy Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Narcolepsy Therapeutics Market Size, 2021 & 2028
5.1.2 Narcolepsy With Cataplexy
5.1.3 Narcolepsy Without Cataplexy
5.1.4 Secondary Narcolepsy
5.2 By Application - Global Narcolepsy Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Narcolepsy Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Narcolepsy Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Narcolepsy Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Narcolepsy Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Narcolepsy Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Narcolepsy Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Narcolepsy Therapeutics Revenue, 2017-2028
6.3.2 US Narcolepsy Therapeutics Market Size, 2017-2028
6.3.3 Canada Narcolepsy Therapeutics Market Size, 2017-2028
6.3.4 Mexico Narcolepsy Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Narcolepsy Therapeutics Revenue, 2017-2028
6.4.2 Germany Narcolepsy Therapeutics Market Size, 2017-2028
6.4.3 France Narcolepsy Therapeutics Market Size, 2017-2028
6.4.4 U.K. Narcolepsy Therapeutics Market Size, 2017-2028
6.4.5 Italy Narcolepsy Therapeutics Market Size, 2017-2028
6.4.6 Russia Narcolepsy Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Narcolepsy Therapeutics Market Size, 2017-2028
6.4.8 Benelux Narcolepsy Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Narcolepsy Therapeutics Revenue, 2017-2028
6.5.2 China Narcolepsy Therapeutics Market Size, 2017-2028
6.5.3 Japan Narcolepsy Therapeutics Market Size, 2017-2028
6.5.4 South Korea Narcolepsy Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Narcolepsy Therapeutics Market Size, 2017-2028
6.5.6 India Narcolepsy Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Narcolepsy Therapeutics Revenue, 2017-2028
6.6.2 Brazil Narcolepsy Therapeutics Market Size, 2017-2028
6.6.3 Argentina Narcolepsy Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Narcolepsy Therapeutics Revenue, 2017-2028
6.7.2 Turkey Narcolepsy Therapeutics Market Size, 2017-2028
6.7.3 Israel Narcolepsy Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Narcolepsy Therapeutics Market Size, 2017-2028
6.7.5 UAE Narcolepsy Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Addrenex Pharmaceuticals, Inc.
7.1.1 Addrenex Pharmaceuticals, Inc. Corporate Summary
7.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
7.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Major Product Offerings
7.1.4 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Addrenex Pharmaceuticals, Inc. Key News
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceutical Industries Ltd. Key News
7.3 Jazz Pharmaceuticals PLC
7.3.1 Jazz Pharmaceuticals PLC Corporate Summary
7.3.2 Jazz Pharmaceuticals PLC Business Overview
7.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Major Product Offerings
7.3.4 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Jazz Pharmaceuticals PLC Key News
7.4 Graymark Healthcare, Inc.
7.4.1 Graymark Healthcare, Inc. Corporate Summary
7.4.2 Graymark Healthcare, Inc. Business Overview
7.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Major Product Offerings
7.4.4 Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Graymark Healthcare, Inc. Key News
7.5 Arena Pharmaceuticals, Inc.
7.5.1 Arena Pharmaceuticals, Inc. Corporate Summary
7.5.2 Arena Pharmaceuticals, Inc. Business Overview
7.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Major Product Offerings
7.5.4 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Arena Pharmaceuticals, Inc. Key News
7.6 BIOPROJET
7.6.1 BIOPROJET Corporate Summary
7.6.2 BIOPROJET Business Overview
7.6.3 BIOPROJET Narcolepsy Therapeutics Major Product Offerings
7.6.4 BIOPROJET Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.6.5 BIOPROJET Key News
7.7 Takeda
7.7.1 Takeda Corporate Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Narcolepsy Therapeutics Major Product Offerings
7.7.4 Takeda Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Takeda Key News
7.8 Ligand Pharmaceuticals, Inc.
7.8.1 Ligand Pharmaceuticals, Inc. Corporate Summary
7.8.2 Ligand Pharmaceuticals, Inc. Business Overview
7.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Major Product Offerings
7.8.4 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Ligand Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer